The global orthopedic biomaterials market is expected to grow at a 7 percent compound annual growth rate between 2018 and 2022, according to a Technavio report.
Three things to know:
1. A key driver of the market is the increasing prevalence of musculoskeletal diseases and disorders.
2. The growing use of nanoparticles in orthopedic bioimplants will significantly propel the market forward over the forecast period.
3. The joint replacement segment held the largest market share in 2017, accounting for around 33 percent. This segment is expected to dominate the market throughout the forecast period.